A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT04869488 · COMPLETED
Trial details
- NCT number
- NCT04869488
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2023-02-14
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.